Zurcher Kantonalbank (Zurich Cantonalbank) - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$701,000
-50.6%
10,291
-76.8%
0.00%
-50.0%
Q2 2022$1,420,000
-8.0%
44,436
-0.3%
0.01%0.0%
Q1 2022$1,544,000
+15.0%
44,583
-2.8%
0.01%
+14.3%
Q4 2021$1,343,000
+35.9%
45,871
+18.3%
0.01%
+40.0%
Q3 2021$988,000
+0.6%
38,772
+38.3%
0.01%0.0%
Q2 2021$982,000
-17.5%
28,031
-4.0%
0.01%
-28.6%
Q1 2021$1,190,000
-8.1%
29,209
-2.3%
0.01%
-12.5%
Q4 2020$1,295,000
+250.9%
29,891
+347.1%
0.01%
+166.7%
Q3 2020$369,000
-12.6%
6,6860.0%0.00%
-25.0%
Q2 2020$422,000
+65.5%
6,686
+33.9%
0.00%
+100.0%
Q1 2020$255,000
-15.8%
4,994
+30.9%
0.00%0.0%
Q4 2019$303,000
+63.8%
3,8140.0%0.00%0.0%
Q3 2019$185,000
+7.6%
3,814
+16.8%
0.00%
+100.0%
Q2 2019$172,000
+17.0%
3,265
+17.3%
0.00%0.0%
Q1 2019$147,000
+14.8%
2,783
-10.4%
0.00%0.0%
Q4 2018$128,000
+8.5%
3,1070.0%0.00%0.0%
Q3 2018$118,000
+0.9%
3,107
+20.1%
0.00%0.0%
Q2 2018$117,000
-29.1%
2,586
-24.4%
0.00%0.0%
Q1 2018$165,000
+44.7%
3,421
+17.8%
0.00%0.0%
Q4 2017$114,000
+56.2%
2,905
+23.4%
0.00%0.0%
Q3 2017$73,000
+14.1%
2,3550.0%0.00%0.0%
Q2 2017$64,000
-13.5%
2,355
+16.6%
0.00%0.0%
Q1 2017$74,0002,0190.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders